Prostatype Genomics AB publishes prospectus
Today, 28 June 2022, Prostatype Genomics AB (”Prostatype Genomics” or the “Company”) publishes the prospectus relating to the Company’s upcoming rights issue, for which the subscription period starts on Wednesday 6 July 2022. The prospectus has today been approved and registered by the Swedish Financial Authority and will be published at the Swedish Financial Authority’s website (www.fi.se). The prospectus is also available on the Company’s ( www.prostatypegenomics.com ),